Nothing Special   »   [go: up one dir, main page]

FI20012509A - New strains of Lactobacillus and their use in the production of food, in particular oatmeal - Google Patents

New strains of Lactobacillus and their use in the production of food, in particular oatmeal Download PDF

Info

Publication number
FI20012509A
FI20012509A FI20012509A FI20012509A FI20012509A FI 20012509 A FI20012509 A FI 20012509A FI 20012509 A FI20012509 A FI 20012509A FI 20012509 A FI20012509 A FI 20012509A FI 20012509 A FI20012509 A FI 20012509A
Authority
FI
Finland
Prior art keywords
lactobacillus
new strains
oatmeal
food
production
Prior art date
Application number
FI20012509A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI110611B (en
Inventor
Goeran Molin
Siv Ahrne
Stig Bengmark
Bengt Jeppson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of FI20012509A publication Critical patent/FI20012509A/en
Application granted granted Critical
Publication of FI110611B publication Critical patent/FI110611B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/857—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Surgical Instruments (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration. By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.
FI20012509A 1991-07-25 2001-12-19 New Lactobacillus strains and their use in food preparation, especially oatmeal FI110611B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9102238 1991-07-25
SE9102238A SE469875C (en) 1991-07-25 1991-07-25 Strain of intestinal colonizing Lactobacillus and composition for prophylaxis or treatment of gastrointestinal infections
SE9200528 1992-07-24
PCT/SE1992/000528 WO1993001823A1 (en) 1991-07-25 1992-07-24 Intestine colonizing lactobacilli

Publications (2)

Publication Number Publication Date
FI20012509A true FI20012509A (en) 2001-12-19
FI110611B FI110611B (en) 2003-02-28

Family

ID=20383375

Family Applications (2)

Application Number Title Priority Date Filing Date
FI931260A FI109357B (en) 1991-07-25 1993-03-22 Method for isolating a Lactobacillus strain
FI20012509A FI110611B (en) 1991-07-25 2001-12-19 New Lactobacillus strains and their use in food preparation, especially oatmeal

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI931260A FI109357B (en) 1991-07-25 1993-03-22 Method for isolating a Lactobacillus strain

Country Status (13)

Country Link
US (3) US5474932A (en)
EP (1) EP0554418B1 (en)
JP (1) JP2742962B2 (en)
AT (1) ATE164073T1 (en)
AU (1) AU659669B2 (en)
CA (1) CA2091557C (en)
DE (1) DE69224814T2 (en)
DK (1) DK0554418T3 (en)
ES (1) ES2114565T3 (en)
FI (2) FI109357B (en)
NO (1) NO306699B1 (en)
SE (1) SE469875C (en)
WO (1) WO1993001823A1 (en)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP2789554B2 (en) * 1994-09-26 1998-08-20 全国農業協同組合連合会 Method for producing alkali-treated yogurt powder having immunological activity
US5733540A (en) * 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
SE9501056D0 (en) * 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
KR100376954B1 (en) * 1995-07-31 2003-07-18 프로비 에이비 Lactobacillus colonized in the intestine
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
ATE298363T1 (en) * 1996-07-09 2005-07-15 Nestle Sa SPRAY DRYING METHOD
GB9623068D0 (en) * 1996-11-06 1997-01-08 Cultech Limited Microflora
SE511524C2 (en) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus strain and pharmaceutical preparation for the control of pathogenic intestinal bacteria
SE510753C2 (en) * 1997-08-05 1999-06-21 Probi Ab Use of a strain of Lactobacillus for the manufacture of a drug for reducing fibrinogen content in blood
RO112995B1 (en) * 1997-08-05 1998-03-30 Rodica Teodorescu Medicinal product for colon therapy
SE511025C2 (en) * 1997-10-03 1999-07-26 Probi Ab Horse feed product comprising Lactobacillus plantarum JI: 1 and Lactobacillus plantarum JI: 1 and use thereof
EP0922391B1 (en) * 1997-12-12 2006-11-22 Karl Müller GmbH & Co. Composition for curing raw sausage
CN1304313A (en) * 1998-06-05 2001-07-18 若素制药株式会社 Lactic acid bacterium-containing compositions, drugs and foods
CN1188140C (en) * 1998-10-01 2005-02-09 普罗比公司 Reduction of oxidative stress factors
FR2785809B1 (en) 1998-11-18 2001-01-12 Gervais Danone Sa SELECTION AND USES OF STRAINS OF LACTIC BACTERIA MODULATING NON-SPECIFIC IMMUNITY
IL143632A0 (en) 1998-12-11 2002-04-21 Urex Biotech Inc Pharmaceutical compositions containing lactobacillus
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
TW588109B (en) * 2000-07-29 2004-05-21 Tcell Biotechnology Food Co Lt Lactobacillus rhamnosus strain and uses thereof
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
MXPA03005465A (en) * 2000-12-18 2004-10-14 Probiohealth Llc Probiotic compounds derived from lactobacillus casei strain ke01.
JP4671384B2 (en) * 2001-05-15 2011-04-13 雪印乳業株式会社 New lactic acid strain
MXPA04001999A (en) * 2001-09-05 2004-07-16 Vsl Pharmaceuticals Inc Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy.
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
SE0103695D0 (en) * 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
WO2004037191A2 (en) * 2002-10-22 2004-05-06 University Of Vermont And State Agriculture College Symbiotic food products comprising oats and methods for manufacturing the same
SE527555C2 (en) * 2003-04-04 2006-04-11 Probi Ab Composition for treating cardiovascular disease, diabetes, cancer, Alzheimer's disease, has tannase-producing strains of Lactobacillus plantarum or Lactobacillus species that adhere to human intestinal mucosa in combination with tannin
CN1207382C (en) * 2003-04-11 2005-06-22 上海光明乳业股份有限公司 Lactob.plantarum ST-III strain and application in regulating blood fat
CN100489086C (en) * 2003-08-21 2009-05-20 大塚制药株式会社 Lactic acid bacteria capable of stimulating mucosal immunity
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) * 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
WO2005085287A1 (en) 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
WO2006046871A2 (en) * 2004-10-29 2006-05-04 N.V. Nutricia Peri-operative composition comprising lactobacillus rhamnosus
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
JP4938005B2 (en) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー Lactobacillus, a feline probiotic
SE529199C2 (en) * 2005-07-05 2007-05-29 Probi Ab Increased absorption
DK2277524T3 (en) 2005-09-28 2016-02-08 Nordisk Rebalance As Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors
EP1769801A1 (en) * 2005-09-28 2007-04-04 Hans Israelsen Use of a fermented cereal composition for the treatment of IBD and IBS
EP2578090B1 (en) 2005-11-17 2018-07-11 Celac Sweden AB New probiotic strains
ES2333259T3 (en) 2005-11-21 2010-02-18 Bioatlantis Limited COMPOSITIONS INTENDED TO IMPROVE INTESTINAL HEALTH AND PERFORMANCE IN ANIMALS THAT INCLUDE BETA-GLUCANOS AND ALFA-FUCANOS.
FR2909526B1 (en) * 2006-12-08 2011-04-01 Gervais Danone Sa FOOD PRODUCT COMPRISING PROBIOTICS AND A LOW PROTON MONOACIDE
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
WO2008105715A2 (en) * 2007-03-01 2008-09-04 Probi Ab Use of lactobacillus plantarum for increasing bacterial diversity
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
SE533778C2 (en) * 2009-05-14 2011-01-11 Probi Ab Probiotic fruit drink
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
NZ600258A (en) * 2009-12-22 2014-01-31 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
KR101840239B1 (en) 2010-01-28 2018-03-20 에이비－바이오틱스, 에스.에이. Probiotic composition for use in the treatment of bowel inflammation
ITMI20110793A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD.
SI24570A (en) 2013-12-23 2015-06-30 Medis D.O.O. New strains of the genus Lactobacillus and use thereof
DE102013022189A1 (en) 2013-12-31 2015-07-02 Carlo Schmelzer Functional beverage and process for its preparation
KR102024883B1 (en) 2017-11-24 2019-09-24 주식회사 고바이오랩 Lactobacillus Fermentum KBL 375 and Use Thereof
AU2019265196B2 (en) 2018-05-09 2022-06-16 Kobiolabs, Inc. Lactobacillus paracasei strain and use thereof
EP3798298A4 (en) 2018-05-23 2022-05-11 Kobiolabs, Inc. Lactobacillus gasseri kbl697 strain and use thereof
CN114007434A (en) 2019-06-05 2022-02-01 森永乳业株式会社 Nutritional composition
WO2023002252A1 (en) 2021-07-21 2023-01-26 Bioatlantis Limited Composition comprising beta-glucans and alpha-fucans for improving gut health and animal performance and methods of making the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
AU624067B2 (en) * 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
DK686187D0 (en) * 1987-12-23 1987-12-23 Hansens Chr Bio Syst VETERINATED PREPARATION
SE463796B (en) * 1988-03-09 1991-01-28 Carl Erik Albertsson PROCEDURES FOR PREPARING A NUTRITIONAL COMPOSITION AND THEREFORE PREPARED NUTRITIONAL COMPOSITION
WO1991005850A1 (en) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Bacterium strain lactobacillus plantarum 38 for production of a bacterial biological preparation
WO1991005851A1 (en) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Bacterium strain lactobacillus casei subsp. casei 37 for production of a bacterial biological preparation
ES2124060T5 (en) * 1992-07-06 2002-12-16 Nestle Sa LACTICAL BACTERIA.

Also Published As

Publication number Publication date
NO931085D0 (en) 1993-03-24
SE469875B (en) 1993-10-04
DK0554418T3 (en) 1999-01-11
NO931085L (en) 1993-03-24
US5587314A (en) 1996-12-24
SE9102238L (en) 1993-01-26
CA2091557A1 (en) 1993-01-26
NO306699B1 (en) 1999-12-13
US5591428A (en) 1997-01-07
EP0554418B1 (en) 1998-03-18
SE469875C (en) 1997-04-14
FI110611B (en) 2003-02-28
CA2091557C (en) 1999-12-21
FI109357B (en) 2002-07-15
ATE164073T1 (en) 1998-04-15
JPH06501624A (en) 1994-02-24
DE69224814T2 (en) 1998-09-03
AU2370992A (en) 1993-02-23
JP2742962B2 (en) 1998-04-22
EP0554418A1 (en) 1993-08-11
US5474932A (en) 1995-12-12
FI931260A0 (en) 1993-03-22
SE9102238D0 (en) 1991-07-25
AU659669B2 (en) 1995-05-25
WO1993001823A1 (en) 1993-02-04
FI931260A (en) 1993-03-22
ES2114565T3 (en) 1998-06-01
DE69224814D1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
FI20012509A (en) New strains of Lactobacillus and their use in the production of food, in particular oatmeal
Meurman et al. Recovery of Lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium
Berg Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole
AU668397B2 (en) Antigastritis agent
US4710379A (en) Intestinal microflora-improving agent
US4746512A (en) Anticariogenic or antiperiodontitic agent
NO169241C (en) PROCEDURE FOR AA ISOLATING A THERAPEUTICALLY APPLICABLE STREAM OF LACTOBACILLUS ACIDOPHILUS
JP2003502375A5 (en)
HUT68567A (en) Biologically clean culture of lactic bacteria, compositions containing it and process of producing it
NO164111C (en) PROCEDURE FOR THE PREPARATION OF AN ANTIBIOTIC ACTIVE 40926 COMPLEX AND ITS PURE FACTORS PA, PB, A, B AND BOMICRON.
EP0524732B1 (en) Composition containing lactic acid bacteria for preventing dental caries
Lutwick et al. Abscess associated with Rothia dentocariosa
US6342366B1 (en) Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microorganisms and a method for inducing and keeping said activity in lactobacilli cultures
RU94013100A (en) Strain of lactobacillus helveticus tiii exhibiting capability to decreased blood serum cholesterol level
Baba et al. Studies on the lytic enzyme from Streptococcus mutans VI The correlation between the lytic ability and bacteriocin activity against Streptococcus sanguis, and artificial plaque forming ability of oral bacteria Streptococcus mutans

Legal Events

Date Code Title Description
MA Patent expired